Literature DB >> 5100251

Dissociative anesthesia for the severely burned child.

G Corssen, S Oget.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5100251

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  10 in total

1.  An appraisal of ketamine in the dressing of burns.

Authors:  C M Ward; A W Diamond
Journal:  Postgrad Med J       Date:  1976-04       Impact factor: 2.401

2.  Rational use of ketamine as an anaesthetic.

Authors:  J B Dillon
Journal:  Proc R Soc Med       Date:  1971-11

3.  Differential effects of ketamine and MK-801 on A-fiber and C-fiber responses of spinal wide dynamic range neurons in the cat.

Authors:  Akira Osada; Yoshihisa Fujino; Jun Chen; Natsu Koyama
Journal:  J Anesth       Date:  1997-09       Impact factor: 2.078

4.  Use of ketamine in prolonged entrapment.

Authors:  R Cottingham; K Thomson
Journal:  J Accid Emerg Med       Date:  1994-09

5.  Anaesthetic management of posterior lumbar osteotomy.

Authors:  D G Wills
Journal:  Can Anaesth Soc J       Date:  1985-05

6.  Anesthesia in cancrum oris.

Authors:  G S Oberoi; P K Bithal; N Saxena; H L Kaul
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

7.  The development of tolerance to ketamine in rats and the significance of hepatic metabolism.

Authors:  A Livingston; A E Waterman
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

8.  Long term high dose morphine, ketamine and midazolam infusion in a child with burns.

Authors:  I Cederholm; M Bengtsson; S Björkman; I Choonara; A Rane
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

Review 9.  The anesthetic management of the severely burned patient.

Authors:  T de Campo; J A Aldrete
Journal:  Intensive Care Med       Date:  1981-01       Impact factor: 17.440

Review 10.  Inclusion body myositis: clinical features and pathogenesis.

Authors:  Steven A Greenberg
Journal:  Nat Rev Rheumatol       Date:  2019-05       Impact factor: 20.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.